Deakin home > Deakin University Library > Deakin Research Online > Pharmaceuticals in Australia: developments in regulation and governance

Pharmaceuticals in Australia: developments in regulation and governance

Lofgren, Hans and de Boer, Rebecca 2004, Pharmaceuticals in Australia: developments in regulation and governance, Social science & medicine, vol. 58, no. 12, pp. 2397-2407.

Attached Files (Some files may be inaccessible until you login with your Deakin Research Online credentials)
Name Description MIMEType Size Downloads

Title Pharmaceuticals in Australia: developments in regulation and governance
Author(s) Lofgren, Hans
de Boer, Rebecca
Journal name Social science & medicine
Volume number 58
Issue number 12
Start page 2397
End page 2407
Publisher Pergamon
Place of publication Oxford, England
Publication date 2004-06
ISSN 0277-9536
Keyword(s) Australia
health policy
networks
partnerships
pharmaceutical industry
politics
regulation
Summary The pharmaceutical domain represents a type of internationalised policy network theorised in recent writings on neo-liberalism, neo-corporatism and governance. This article presents an analysis of developments in prescription drug regulation in Australia. A relatively stable, state-managed pattern of interaction has been superseded by less closed exchange, and the government itself has fragmented into agencies pursuing different objectives. Developments in the three core regulatory areas are described: safety and efficacy controls, social policy (access and equity), and state support for industry (economic) development. Consensus-building occurs within the context of the National Medicines Policy. The pharmaceutical industry, represented by Medicines Australia, has a stake in all aspects of pharmaceutical policy and regulation, and draws upon unique resources (expertise and lobbying capacity). The context for the developments described is Australia's abandonment of a protectionist version of the Keynesian welfare national state in favour of the model of the competition state, which is oriented towards support for the growth of high technology industries such as pharmaceuticals, premised on partnerships with business.
Notes Available online 21 October 2003.
Language eng
Field of Research 169999 Studies in Human Society not elsewhere classified
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2003, Elsevier Ltd
Persistent URL http://hdl.handle.net/10536/DRO/DU:30002505

Document type: Journal Article
Collection: School of Social and International Studies
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in Deakin Research Online is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 14 times in TR Web of Science
Scopus Citation Count Cited 16 times in Scopus
Access Statistics: 464 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Mon, 07 Jul 2008, 08:26:37 EST